SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-112264
Filing Date
2021-09-02
Accepted
2021-09-02 09:19:13
Documents
13
Period of Report
2021-08-27
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2126709d1_8k.htm   iXBRL 8-K 29207
2 EXHIBIT 99.1 tm2126709d1_ex99-1.htm EX-99.1 252746
  Complete submission text file 0001104659-21-112264.txt   477109

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA osmt-20210827.xsd EX-101.SCH 3188
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE osmt-20210827_lab.xml EX-101.LAB 34593
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE osmt-20210827_pre.xml EX-101.PRE 22712
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2126709d1_8k_htm.xml XML 3607
Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
Osmotica Pharmaceuticals plc (Filer) CIK: 0001739426 (see all company filings)

IRS No.: 000000000
Type: 8-K | Act: 34 | File No.: 001-38709 | Film No.: 211231843
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences